Subscribe to Newsletter

Business & Regulation

Business & Regulation Trends & Forecasts

The Future of Smarter, More Personalized Medicines

Experts share their insights on the disruptive trends reshaping healthcare, including the rise of personalized medicine and digital innovation.

Business & Regulation Trends & Forecasts

The Opportunities to Further Advance Drug Development

| 2 min read

Alcami experts discuss what’s needed to accelerate drug development.

Business & Regulation Standards & Regulation

EFPIA Calls For Clarity Over JCA Concerns

| Rob Coker | 2 min read

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.

Business & Regulation Digital Technologies

The Rise of Digital Health

| 2 min read

From wearable health tech to telehealth, here’s how digital transformation could impact the pharma industry and patient access.

Business & Regulation Business Practice

Proactive Pharmacovigilance is the Game Changer Biotech Needs

| Laura Hopper | 3 min read

Why a forward-thinking approach is crucial for patient safety and industry success

Business & Regulation Digital Technologies

AI and the Copyright Question for R&D

| Rob Coker | 2 min read

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

Business & Regulation Trends & Forecasts

Smart and Sustainable: Pharma’s Future

| 3 min read

How will digitalization and automation redefine pharma manufacturing in the next decade?

Business & Regulation Business Practice

So, You’ve Acquired A Company… Now What?

| Andrew Henderson | 8 min read

Now, it’s time to start the integration process. Here are some top tips and points to consider.

Business & Regulation Trends & Forecasts

Getting Drugs to Patients Faster

| 2 min read

Colleen Dixon and Mary Glotzbach discuss key areas for improvement, including automation, eco-friendly practices, and patient-centric delivery methods

Business & Regulation Trends & Forecasts

Analyzing Access: Novartis is the New Leader in the 2024 Access to Medicine Index

| Rob Coker

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker